These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 15662033)
1. Central role of PKCbeta in neointimal expansion triggered by acute arterial injury. Andrassy M; Belov D; Harja E; Zou YS; Leitges M; Katus HA; Nawroth PP; Yan SD; Schmidt AM; Yan SF Circ Res; 2005 Mar; 96(4):476-83. PubMed ID: 15662033 [TBL] [Abstract][Full Text] [Related]
2. Reduction of PKCbetaII activity in smooth muscle cells attenuates acute arterial injury. Huang C; Chang JS; Xu Y; Li Q; Zou YS; Yan SF Atherosclerosis; 2010 Sep; 212(1):123-30. PubMed ID: 20594553 [TBL] [Abstract][Full Text] [Related]
3. PKCbeta modulates ischemia-reperfusion injury in the heart. Kong L; Andrassy M; Chang JS; Huang C; Asai T; Szabolcs MJ; Homma S; Liu R; Zou YS; Leitges M; Yan SD; Ramasamy R; Schmidt AM; Yan SF Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1862-70. PubMed ID: 18245560 [TBL] [Abstract][Full Text] [Related]
4. Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization. Ikesue M; Matsui Y; Ohta D; Danzaki K; Ito K; Kanayama M; Kurotaki D; Morimoto J; Kojima T; Tsutsui H; Uede T Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1066-74. PubMed ID: 21330609 [TBL] [Abstract][Full Text] [Related]
6. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511 [TBL] [Abstract][Full Text] [Related]
7. Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis. Harja E; Chang JS; Lu Y; Leitges M; Zou YS; Schmidt AM; Yan SF FASEB J; 2009 Apr; 23(4):1081-91. PubMed ID: 19036858 [TBL] [Abstract][Full Text] [Related]
8. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt. Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373 [TBL] [Abstract][Full Text] [Related]
9. Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbetaII. Campbell M; Trimble ER Circ Res; 2005 Feb; 96(2):197-206. PubMed ID: 15591231 [TBL] [Abstract][Full Text] [Related]
10. Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases. Yao JS; Chen Y; Zhai W; Xu K; Young WL; Yang GY Circ Res; 2004 Aug; 95(4):364-71. PubMed ID: 15256478 [TBL] [Abstract][Full Text] [Related]
11. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337 [TBL] [Abstract][Full Text] [Related]
13. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Calabro P; Samudio I; Willerson JT; Yeh ET Circulation; 2004 Nov; 110(21):3335-40. PubMed ID: 15545519 [TBL] [Abstract][Full Text] [Related]
14. Atorvastatin sensitises vascular smooth muscle cells, but not endothelial cells, to TNF-α-induced cell death. Giordano A; Romano S; Nappo G; Messina S; Polimeno M; Corcione N; Cali G; Ferraro P; Monaco M; Zambrano N; Romano MF Curr Pharm Des; 2012; 18(38):6331-8. PubMed ID: 23092297 [TBL] [Abstract][Full Text] [Related]
15. Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo. Schwaiberger AV; Heiss EH; Cabaravdic M; Oberan T; Zaujec J; Schachner D; Uhrin P; Atanasov AG; Breuss JM; Binder BR; Dirsch VM Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2475-81. PubMed ID: 20847306 [TBL] [Abstract][Full Text] [Related]
16. Soluble Flt-1 gene transfer ameliorates neointima formation after wire injury in flt-1 tyrosine kinase-deficient mice. Koga J; Matoba T; Egashira K; Kubo M; Miyagawa M; Iwata E; Sueishi K; Shibuya M; Sunagawa K Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):458-64. PubMed ID: 19164801 [TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor antagonizes transforming growth factor-beta1-induced smooth muscle gene expression through extracellular signal-regulated kinase 1/2 signaling pathway activation. Kawai-Kowase K; Sato H; Oyama Y; Kanai H; Sato M; Doi H; Kurabayashi M Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1384-90. PubMed ID: 15217807 [TBL] [Abstract][Full Text] [Related]
18. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury. Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953 [TBL] [Abstract][Full Text] [Related]
19. Regulation of plasminogen activators in human thyroid follicular cells and their relationship to differentiated function. Susarla R; Watkinson JC; Eggo MC J Cell Physiol; 2007 Sep; 212(3):643-54. PubMed ID: 17458906 [TBL] [Abstract][Full Text] [Related]
20. Protein kinase C-delta regulates migration and proliferation of vascular smooth muscle cells through the extracellular signal-regulated kinase 1/2. Liu B; Ryer EJ; Kundi R; Kamiya K; Itoh H; Faries PL; Sakakibara K; Kent KC J Vasc Surg; 2007 Jan; 45(1):160-8. PubMed ID: 17210402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]